• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Using circulating tumor DNA to monitor myelodysplastic syndromes status.

作者信息

Zhao Pan, Qin Jiayue, Liu Weiyi, Zhu Qianze, Fan Teng, Xiao Haiyan, Wang Juan, Huang Gang, Xiaomei Hu

机构信息

Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Hematol Oncol. 2019 Oct;37(4):531-533. doi: 10.1002/hon.2649. Epub 2019 Aug 11.

DOI:10.1002/hon.2649
PMID:31291480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6900042/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6900042/c40d9178495e/HON-37-531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6900042/4c9d4d6ea65d/HON-37-531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6900042/c40d9178495e/HON-37-531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6900042/4c9d4d6ea65d/HON-37-531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1b/6900042/c40d9178495e/HON-37-531-g002.jpg

相似文献

1
Using circulating tumor DNA to monitor myelodysplastic syndromes status.利用循环肿瘤DNA监测骨髓增生异常综合征状态。
Hematol Oncol. 2019 Oct;37(4):531-533. doi: 10.1002/hon.2649. Epub 2019 Aug 11.
2
Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia.循环肿瘤DNA对骨髓增生异常综合征和急性髓系白血病临床结局的连续监测
Clin Transl Med. 2023 Jul;13(7):e1349. doi: 10.1002/ctm2.1349.
3
Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges.循环肿瘤 DNA 在骨髓增生异常综合征和急性髓系白血病中的应用：前景与挑战。
Front Biosci (Landmark Ed). 2024 Feb 22;29(2):86. doi: 10.31083/j.fbl2902086.
4
Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome.环状 RNA 在造血中的作用，重点是急性髓系白血病和骨髓增生异常综合征。
Int J Mol Sci. 2020 Aug 19;21(17):5972. doi: 10.3390/ijms21175972.
5
[Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].[骨髓增生异常（MDP）综合征的临床症状与分子紊乱]
Pol Arch Med Wewn. 1992 Mar;87(3):197-208.
6
Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.骨髓增生异常综合征患者外周血 WT1 mRNA 和抗 WT1 抗体水平的预后意义。
Leuk Res. 2010 Aug;34(8):986-90. doi: 10.1016/j.leukres.2009.11.029. Epub 2010 Jan 19.
7
Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant.异基因造血干细胞移植后急性髓系白血病和骨髓增生异常综合征患者移植前血清铁蛋白评分系统与疾病风险的多中心验证
Leuk Lymphoma. 2013 Jun;54(6):1318-20. doi: 10.3109/10428194.2012.730613. Epub 2012 Nov 1.
8
Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup Study.活检与抗VIII因子抗体呈反应性的急性髓系白血病和骨髓增生异常综合征患者的细胞周期及临床特征。一项白血病协作组研究。
Leuk Res. 1991;15(1):51-7. doi: 10.1016/0145-2126(91)90144-i.
9
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.转化生长因子 β1 介导的骨髓增生异常综合征和急性髓系白血病间充质基质细胞功能抑制。
Haematologica. 2018 Sep;103(9):1462-1471. doi: 10.3324/haematol.2017.186734. Epub 2018 May 17.
10
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.NPM1突变可能会在形态学上被诊断为骨髓增生异常综合征或骨髓增生异常/骨髓增殖性肿瘤的病例中揭示急性髓系白血病。
Leuk Lymphoma. 2015;56(11):3222-6. doi: 10.3109/10428194.2015.1026900. Epub 2015 May 12.

引用本文的文献

1
Liquid biopsy in cancer current: status, challenges and future prospects.癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
2
Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia.循环肿瘤DNA对骨髓增生异常综合征和急性髓系白血病临床结局的连续监测
Clin Transl Med. 2023 Jul;13(7):e1349. doi: 10.1002/ctm2.1349.
3
Dynamic change of variant allele frequency reveals disease status, clonal evolution and survival in pediatric relapsed B-cell acute lymphoblastic leukaemia.

本文引用的文献

1
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.克隆异质性与肿瘤演进：过去、现在与未来。
Cell. 2017 Feb 9;168(4):613-628. doi: 10.1016/j.cell.2017.01.018.
2
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.使用循环肿瘤 DNA 进行骨髓增生异常综合征的分子疾病监测。
Blood. 2017 Mar 23;129(12):1685-1690. doi: 10.1182/blood-2016-09-740308. Epub 2017 Jan 26.
3
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.TP53与地西他滨在急性髓系白血病和骨髓增生异常综合征中的应用
变异等位基因频率的动态变化揭示了儿童复发性B细胞急性淋巴细胞白血病的疾病状态、克隆进化和生存情况。
Clin Transl Med. 2022 May;12(5):e892. doi: 10.1002/ctm2.892.
4
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.循环游离 DNA 中骨髓增生异常综合征的分子和细胞遗传学特征。
Blood Adv. 2022 May 24;6(10):3178-3188. doi: 10.1182/bloodadvances.2021006565.
5
Role of Circulating Tumor DNA in Hematological Malignancy.循环肿瘤DNA在血液系统恶性肿瘤中的作用
Cancers (Basel). 2021 Apr 25;13(9):2078. doi: 10.3390/cancers13092078.
6
Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis.循环肿瘤DNA在血液系统恶性肿瘤（淋巴瘤、多发性骨髓瘤、骨髓增生异常综合征和白血病）中的临床价值：一项荟萃分析
Front Oncol. 2021 Mar 4;11:632910. doi: 10.3389/fonc.2021.632910. eCollection 2021.
N Engl J Med. 2016 Nov 24;375(21):2023-2036. doi: 10.1056/NEJMoa1605949.
4
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.外周血游离DNA是反映骨髓增生异常综合征疾病状态的一种替代性肿瘤DNA来源。
Cancer Sci. 2016 Sep;107(9):1329-37. doi: 10.1111/cas.12994. Epub 2016 Aug 25.
5
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.未经治疗的弥漫性大B细胞淋巴瘤患者的循环肿瘤DNA与CT监测：一项相关生物标志物研究
Lancet Oncol. 2015 May;16(5):541-9. doi: 10.1016/S1470-2045(15)70106-3. Epub 2015 Apr 1.
6
Detection of circulating tumor DNA in early- and late-stage human malignancies.早期和晚期人类恶性肿瘤中循环肿瘤DNA的检测
Sci Transl Med. 2014 Feb 19;6(224):224ra24. doi: 10.1126/scitranslmed.3007094.
7
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.BCOR 和 BCORL1 突变在骨髓增生异常综合征及相关疾病中的作用。
Blood. 2013 Oct 31;122(18):3169-77. doi: 10.1182/blood-2012-11-469619. Epub 2013 Sep 18.
8
Landscape of TET2 mutations in acute myeloid leukemia.急性髓系白血病中 TET2 突变的全景。
Leukemia. 2012 May;26(5):934-42. doi: 10.1038/leu.2011.326. Epub 2011 Nov 25.
9
Clinical effect of point mutations in myelodysplastic syndromes.骨髓增生异常综合征点突变的临床疗效。
N Engl J Med. 2011 Jun 30;364(26):2496-506. doi: 10.1056/NEJMoa1013343.
10
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).TET2突变是骨髓增生异常综合征（MDS）中一个独立的有利预后因素。
Blood. 2009 Oct 8;114(15):3285-91. doi: 10.1182/blood-2009-04-215814. Epub 2009 Aug 7.